NCT01919489View on ClinicalTrials.gov

Liraglutide Hospital Discharge Trial

PHASE4CompletedINTERVENTIONAL
Enrollment

273

Participants

Timeline

Start Date

March 31, 2014

Primary Completion Date

August 30, 2020

Study Completion Date

August 30, 2020

Conditions
Type 2 Diabetes
Interventions
DRUG

Liraglutide + OADs

Liraglutide subcutaneously daily

DRUG

Glargine + OADs

Glargine once daily subcutaneously

Trial Locations (5)

30303

Grady Memorial Hospital, Atlanta

30324

Emory University Hospital, Atlanta

Unknown

University of Miami, Miami

Emory Universtiy Hospital at MIdtown, Atlanta

State University of NY at Buffalo, New York

Sponsors

Collaborators (1)

Novo Nordisk A/S
All Listed Sponsors
collaborator

Novo Nordisk A/S

INDUSTRY

lead

Emory University

OTHER